What is Type 1 Diabetes?
Type 1 diabetes is an autoimmune condition in which your immune system attacks the insulin-producing beta cells in your pancreas.
The primary effect of type 1 diabetes is that it dramatically reduces the ability of your body to produce insulin, the master hormone responsible for promoting glucose uptake into cells in many tissues.
Without enough endogenous (self-made) insulin, people with type 1 diabetes require exogenous insulin, injected as needed via a syringe, pen, or insulin pump.
Inhaled insulin is also an option, albeit far less common.
DKA is characterized by extremely high blood glucose levels (above 300 mg/dL) which result in excessive thirst, excessive hunger, unexplained weight loss, frequent urination, muscle cramping, and low energy.
Currently, estimates are that up to 10% of the US population lives with diabetes (34.2 million), with about 5% of that overall number living with type 1 diabetes (1.5-2 million people).
Researchers have been unable to isolate one specific cause of type 1 diabetes, but increasing evidence shows that there may be a number of different environmental triggers including specific proteins found in food, as well as viruses and bacteria.
This article will focus on some common symptoms of type 1 diabetes, the difference between type 1 and type 2 diabetes, and whether or not genetics affect your likelihood of getting type 1 diabetes.
We'll also discuss treatment options for type 1 diabetes, and how a plant-based, whole food diet may dramatically improve your quality of life if you’re currently living with type 1 diabetes.
Symptoms of Type 1 Diabetes
No matter when type 1 diabetes is diagnosed, the initial symptoms include, but are not limited to:
It’s important to understand that type 1 diabetes is a serious condition, and can dramatically increase your risk for other chronic diseases in the long term if your blood sugar remains uncontrolled.
Aside from the symptoms mentioned above, research suggests that 65% of people living with type 1 diabetes for more than 20 years will die of heart disease, as a result of high blood pressure, high blood glucose, and other complications.
This same research demonstrates that more than 50% of people living with type 1 diabetes for more than 30 years will die of kidney failure.
Fortunately, there are well-tested, evidence-based methods to manage type 1 diabetes, which we’ll cover below.
What's the Difference Between Type 1 and Type 2 Diabetes?
The main difference between type 1 and type 2 diabetes is simple. Type 1 diabetes is an autoimmune condition in which your body’s immune system mistakenly targets insulin-producing beta cells for destruction.
The process of autoimmunity begins with molecular mimicry, a sneaky tactic used by various bacteria and viruses in which pathogenic proteins attempt to evade detection by the human immune system by “disguising” themselves as mammalian proteins.
In both young children and adults, microscopic holes in the gut lining allow pathogenic proteins to pass directly from your digestive system into your blood before they have been sufficiently broken down by digestive enzymes.
Once these pathogenic proteins are present in your blood, your immune system recognizes them as foreign proteins and mounts an immune response that targets them for destruction.
But because these pathogenic proteins contain specific regions that mimic proteins found in your body, your immune system can mistakenly target proteins on human cells in tissues all over your body for destruction, setting the stage for an autoimmune reaction.
Think of type 1 diabetes as a form of biological “friendly fire” in which your immune system is hijacked by a pathogenic protein that tricks it into destroying critical human cells containing proteins with a similar structure on the surface of insulin-producing beta cells.
Type 2 diabetes, on the other hand, is not an autoimmune condition.
The majority of people with type 2 diabetes are able to produce sufficient insulin, but suffer from insulin resistance – a condition in which cells in your muscle and liver can’t respond to insulin effectively.
Insulin resistance not only causes prediabetes and type 2 diabetes, it increases your risk for many chronic diseases like coronary artery disease, atherosclerosis, cancer, polycystic ovary syndrome (PCOS), peripheral neuropathy, Alzheimer’s disease, chronic kidney disease, and fatty liver disease (NAFLD).
According to the most recent research, 5-10% of people with diabetes have type 1 diabetes (about 1.5-2 million people) while between 90-95% of people with diabetes have type 2 diabetes (about 32 million).
Type 1 Diabetes and Insulin Resistance
Type 1 diabetes and insulin resistance are rarely referenced in the same context, since insulin resistance is the cause of type 2 diabetes.
However, insulin resistance is the underlying condition that causes high blood glucose and significant long-term tissue damage in people with type 1 diabetes.
This matters because insulin resistance is actually exacerbated by a high-fat, low-carbohydrate diet in people with type 1 diabetes, just like in people living with type 2 diabetes.
An animal-based ketogenic diet, a plant-based ketogenic diet, and a Paleo diet are all high-fat diets that are commonly prescribed for those with type 1 diabetes.
Because of this, it’s extremely important to be aware that even though severely reducing the grams of carbohydrates you consume by following a high-fat diet may help you control your blood glucose in the short-term, this may increase your chronic disease risk in the long-term.
Is Type 1 Diabetes Genetic?
Genetics likely play a role in the development of type 1 diabetes, but the research is currently unclear on the exact molecular mechanisms.
Scientists have been unable to isolate the exact mechanisms by which specific genes can influence your risk for type 1 diabetes, even though a genetic connection does exist.
According to the NIH, “A predisposition to develop type 1 diabetes is passed through generations in families, but the inheritance pattern is unknown.”
Fortunately, in almost all cases, you can effectively manage type 1 diabetes through healthy eating using a low-fat, plant-based, whole-food diet.
How is Type 1 Diabetes Treated?
In general, the treatment methodology for type 1 diabetes centers around monitoring blood glucose levels using a blood glucose monitor. Based on your blood glucose levels, the typical treatment model then prescribes a specific insulin dose, which is injected by an insulin pump, syringe, or pen.
Think of these insulin injections as a supplement to the insulin produced by your body (if any at all), in order to maintain your blood glucose within range.
The ‘Typical’ Treatment Model
Recently, many doctors have begun to follow a treatment methodology utilizing strategic lifestyle changes to improve blood glucose control.
Some of these recommendations, like increased physical activity, and reducing or eliminating refined sugars and other refined ingredients, can dramatically improve blood glucose control and reduce your risk for long-term complications.
Though these diets (Keto, Paleo, Atkins) can provide short-term results, over time they can actually result in increased insulin use, increased oral medication use, and increased A1c over time.
This may sound very different from what you’ve heard, and we know that can be surprising! Keep reading and we’ll explain why high-fat, low-carbohydrate diets are not ideal for people living with type 1 diabetes.
The Problem with High-Fat, Low-Carbohydrate Diets
The main issue with the current low-carbohydrate diets is that they ignore the underlying causes of high blood glucose levels (insulin resistance), and instead prescribe a ‘quick fix’.
In many cases, the high-fat, low carbohydrate intake approach results in low A1c values, reduced insulin requirements, weight loss, reduced fasting insulin, reduced fasting glucose, reduced triglycerides, and increased HDL cholesterol in the short-term.
If you’d like to read more about exactly why carb counting and a low carbohydrate diet isn’t right for you, you can dive even deeper into the science in this article debunking 7 misleading statements about ketosis and ketogenic diets.
The Low-Fat, Plant-Based, Whole-Food Nutrition to Maximize Insulin Sensitivity
For a long term solution, the research instead points to a low-fat, plant-based, whole-food diet that’s high in whole carbohydrates. This healthy diet results in dramatically increased insulin sensitivity, which also results in:
Is Type 1 Diabetes Reversible?
The idea that type 1 diabetes can be reversed is misleading. Though much research is being done on type 1 diabetes, at the moment type 1 diabetes has no known cure.
However, type 1 diabetes can be effectively managed, so that the risk of developing long-term complications is minimized.
Currently, the most effective way to manage the underlying causes and risks of type 1 diabetes are through a low-fat, plant-based, whole-food diet as described below.
Diabetes Management Through Diet: Guidelines
Red Light, Green Light, Yellow Light Foods
The diet guidelines for managing your blood glucose levels while living with type 1 diabetes are actually very simple, following a clear “green light, yellow light, red light,” categorization for foods.
“Green light” foods include all fruits (except avocado, durian, and dates), starchy and non-starchy vegetables, all legumes (except soybeans), intact whole grains (minimally processed), and herbs and spices.
Green light foods are foods that you can eat as much as you want, as these are unrefined whole foods low in fat with a high nutrient density that have been demonstrated to reverse insulin resistance.
“Yellow light” foods include whole grain or bean pastas, whole grain cereals, refined grains, whole grain bread and tortillas, avocados, nuts, seeds, coconut meat, soybeans, and soy products.
Yellow light foods are foods okay to include in small quantities, because they are slightly processed or have higher fat content. They shouldn’t be daily staples, but are still considered a “healthy” choice.
“Red light” foods include all red meats, all white meats, all seafood, eggs, dairy products, refined oils, and refined sugars (simple carbohydrates).
Red light foods are foods that we recommend removing from your cabinet, your fridge, and your plate.
These foods are documented by evidence-based research to cause insulin resistance, increase your blood glucose (fasting and post-meal), and promote chronic diseases in individuals with type 1 diabetes.
Compared to What You’ve Heard
The major difference between the low-fat, plant-based, whole food diet, a low-carbohydrate diet, or other methods like the glycemic index becomes apparent in the long-term.
Low-carb diets provide quick results, but as we mentioned above, they can drastically increase insulin resistance and therefore increase your risk for many chronic diseases in the long term.
The glycemic index also focuses on the short term effects of specific foods, rather than increasing the nutrient density of your overall diet.
Meanwhile, the low-fat, plant-based, whole food diet provides excellent short-term results and dramatically reduces your risk for chronic diseases like coronary artery disease, atherosclerosis, cancer, obesity, polycystic ovary syndrome (PCOS), peripheral neuropathy, Alzheimer’s disease, chronic kidney disease, and fatty liver disease in the future.
One of the largest communities surrounding low-fat, plant-based, whole-food diets is right here at Mastering Diabetes, where thousands of people have already regained control of their blood glucose, lost weight, and improved their energy and overall health just by changing their diet.
For example, Affaf was able to regain control of her life after years on the “blood glucose rollercoaster,” in what she calls a total type 1 diabetes makeover.
After following the low-carbohydrate diet to the T and exercising frequently, Regina was still gaining weight and had an A1c over 12.0%.
After switching to a low-fat, plant-based, whole-food diet, Regina cut her A1c by more than a half by her next doctor’s visit.
We’ve got a helpful, comprehensive guide for your food choices below.
Type 1 Diabetes Diet: Foods to Eat and Avoid
Example Type 1 Diabetes Meal Plan
One of the biggest challenges people face when switching to a low-fat, plant-based, whole-food diet is the feeling like they’re giving up some of their favorite foods.
The reason: almost all of the red light foods are rich in saturated fat, refined sugars, protein, or synthetic texturizers and fillers, and many are manufactured in a laboratory to taste good.
To help overcome this challenge, we have two recommendations.
Recommendation #1: For best results when transitioning to a low-fat, plant-based, whole-food diet, transition gradually.
To help with the feeling that you’re giving something up, we recommend changing one of your meals each week, starting first with breakfast, then breakfast and lunch, until finally all three meals of the day are fully optimized.
Recommendation #2: Eat a wide variety of foods from our recipe database, which is full of suggestions for breakfast, lunch, dinner, desserts, and snacks that taste great, are great for you, and are 100% low-fat, plant-based, and whole-food approved. We created the chart below to assist you with meal planning.
*Note: Even in meals that have ‘no change’, we recommend replacing one red light food with a yellow light or green light food, or even trying to eat yellow and green light foods exclusively. Even one change of ingredients can have significant positive benefits for your diabetes health.
Week 1 Meal Plan
Week 2 Meal Plan
Week 3 Meal Plan
If you would like personal guidance, recommended recipes, or advice in making the transition or adjusting your diabetes nutrition to fit your personal needs, you can work with our coaches in the Mastering Diabetes Coaching Program.
Other Articles You Might Like...
Mastering Diabetes has strict guidelines for scientific references in our articles. We rely on peer-reviewed studies, academic research institutions, governmental organizations, and reputable medical organizations. We do our best to avoid using non evidence-based references in all articles. The references in this article are listed below.
“A Practical Review of C-Peptide Testing in Diabetes | SpringerLink.” https://link.springer.com/article/10.1007/s13300-017-0265-4.
Glycemic Index Foundation. “About Glycemic Index.” https://www.gisymbol.com/about-glycemic-index/.
“Adverse Metabolic Effects of Dietary Fructose: Results from... : Current Opinion in Lipidology.” https://journals.lww.com/co-lipidology/Abstract/2013/06000/Adverse_metabolic_effects_of_dietary_fructose__.4.aspx.
“Afrezza Inhalable Insulin Powder.”
Atkinson, Mark A, George S Eisenbarth, and Aaron W Michels. “Type 1 Diabetes.” Lancet 383, no. 9911 (January 4, 2014): 69–82. https://doi.org/10.1016/S0140-6736(13)60591-7.
“Both Dietary Protein and Fat Increase Postprandial Glucose Excursions in Children With Type 1 Diabetes, and the Effect Is Additive | Diabetes Care.” https://care.diabetesjournals.org/content/36/12/3897.
CDC. “Type 1 Diabetes.” Centers for Disease Control and Prevention, March 11, 2020. https://www.cdc.gov/diabetes/basics/type1.html.
Commissioner, Office of the. “Insulin.” FDA, February 21, 2020. https://www.fda.gov/consumers/free-publications-women/insulin.
Depth, Clara Rodríguez Fernández-03/03/2020 8 mins- In. “How Immunotherapy Could Stop and Prevent Type 1 Diabetes.” Labiotech.eu, March 3, 2020. https://www.labiotech.eu/in-depth/immunotherapy-type-1-diabetes/.
National Institute of Diabetes and Digestive and Kidney Diseases. “Diabetes in America, 3rd Edition | NIDDK.” https://www.niddk.nih.gov/about-niddk/strategic-plans-reports/diabetes-in-america-3rd-edition.
“Diabetes Quick Facts | Basics | Diabetes | CDC,” June 11, 2020. https://www.cdc.gov/diabetes/basics/quick-facts.html.
“Diabetes Recipes: Low-Fat, Plant-Based, Whole-Food Nutrition.” https://www.masteringdiabetes.org/recipe/.
“Diagnosis and Classification of Diabetes Mellitus.” Diabetes Care 33, no. Suppl 1 (January 2010): S62–69. https://doi.org/10.2337/dc10-S062.
DiMeglio, Linda A, Carmella Evans-Molina, and Richard A Oram. “Type 1 Diabetes.” Lancet (London, England) 391, no. 10138 (June 16, 2018): 2449–62. https://doi.org/10.1016/S0140-6736(18)31320-5.
“Easy-to-Follow Guidelines to Reverse Insulin Resistance.” https://www.masteringdiabetes.org/diabetes-nutrition-guidelines/.
“Exercise as a Therapeutic Intervention for the Prevention and Treatment of Insulin Resistance - Hawley - 2004 - Diabetes/Metabolism Research and Reviews - Wiley Online Library.” https://onlinelibrary.wiley.com/doi/abs/10.1002/dmrr.505.
Han, Ling, Lijin Ji, Jing Chang, Jian Wen, Wenting Zhao, Hongli Shi, Linuo Zhou, et al. “Peripheral Neuropathy Is Associated with Insulin Resistance Independent of Metabolic Syndrome.” Diabetology & Metabolic Syndrome 7, no. 1 (March 3, 2015): 14. https://doi.org/10.1186/s13098-015-0010-y.
Health, Center for Devices and Radiological. “Blood Glucose Monitoring Devices.” FDA. FDA, May 3, 2019. https://www.fda.gov/medical-devices/vitro-diagnostics/blood-glucose-monitoring-devices.
“High Carb Foods Proven to Reverse Insulin Resistance & Type 2 Diabetes.” https://www.masteringdiabetes.org/high-carb-foods-reverse-insulin-resistance/.
“Insulin Resistance and Cancer Risk: An Overview of the Pathogenetic Mechanisms.” https://www.hindawi.com/journals/jdr/2012/789174/.
“Insulin Resistance and Coronary Heart Disease in Nondiabetic Individuals | Arteriosclerosis, Thrombosis, and Vascular Biology.” https://www.ahajournals.org/doi/10.1161/ATVBAHA.111.241885.
“Insulin Resistance, Hypertension, and Coronary Heart Disease - Reaven - 2003 - The Journal of Clinical Hypertension - Wiley Online Library.” https://onlinelibrary.wiley.com/doi/full/10.1111/j.1524-6175.2003.01764.x.
Kahanovitz, Lindy, Patrick M. Sluss, and Steven J. Russell. “Type 1 Diabetes – A Clinical Perspective.” Point of Care 16, no. 1 (March 2017): 37–40. https://doi.org/10.1097/POC.0000000000000125.
Mastering Diabetes. “Ketosis and the Ketogenic Diet: Debunking 7 Misleading Statements,” February 15, 2018. https://www.masteringdiabetes.org/ketosis-ketogenic-diets-misleading/.
Korenblat, Kevin M., Elisa Fabbrini, B. Selma Mohammed, and Samuel Klein. “Liver, Muscle, and Adipose Tissue Insulin Action Is Directly Related to Intrahepatic Triglyceride Content in Obese Subjects.” Gastroenterology 134, no. 5 (May 1, 2008): 1369–75. https://doi.org/10.1053/j.gastro.2008.01.075.
Leighton, Emma, Christopher AR Sainsbury, and Gregory C. Jones. “A Practical Review of C-Peptide Testing in Diabetes.” Diabetes Therapy 8, no. 3 (June 1, 2017): 475–87. https://doi.org/10.1007/s13300-017-0265-4.
Lennerz, Belinda S., Anna Barton, Richard K. Bernstein, R. David Dikeman, Carrie Diulus, Sarah Hallberg, Erinn T. Rhodes, et al. “Management of Type 1 Diabetes With a Very Low–Carbohydrate Diet.” Pediatrics 141, no. 6 (June 2018): e20173349. https://doi.org/10.1542/peds.2017-3349.
Lim, S. S., N. S. Kakoly, J. W. J. Tan, G. Fitzgerald, M. Bahri Khomami, A. E. Joham, S. D. Cooray, et al. “Metabolic Syndrome in Polycystic Ovary Syndrome: A Systematic Review, Meta-Analysis and Meta-Regression.” Obesity Reviews 20, no. 2 (2019): 339–52. https://doi.org/10.1111/obr.12762.
“Linking Chronic Infection and Autoimmune Diseases: Mycobacterium Avium Subspecies Paratuberculosis, SLC11A1 Polymorphisms and Type-1 Diabetes Mellitus.” https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0007109.
“Living with Type 1 Diabetes: How to Lower A1c to 5.3%.” https://www.masteringdiabetes.org/how-to-lower-a1c-regina-type-1-diabetes/.
“National Diabetes Statistics Report | Data & Statistics | Diabetes | CDC,” May 5, 2020. https://www.cdc.gov/diabetes/data/statistics/statistics-report.html.
Neu, Andreas, Fabian Behret, Regina Braun, Susann Herrlich, Franziska Liebrich, Martina Loesch‐Binder, Angelika Schneider, and Roland Schweizer. “Higher Glucose Concentrations Following Protein- and Fat-Rich Meals – the Tuebingen Grill Study: A Pilot Study in Adolescents with Type 1 Diabetes.” Pediatric Diabetes 16, no. 8 (2015): 587–91. https://doi.org/10.1111/pedi.12224.
Nielsen, Jørgen Vesti, Eva Jönsson, and Anette Ivarsson. “A Low Carbohydrate Diet in Type 1 Diabetes: Clinical Experience--a Brief Report.” Upsala Journal of Medical Sciences 110, no. 3 (2005): 267–73. https://doi.org/10.3109/2000-1967-074.
O’ Neill, Daniel F., Eric C. Westman, and Richard K. Bernstein. “The Effects of a Low-Carbohydrate Regimen on Glycemic Control and Serum Lipids in Diabetes Mellitus.” Metabolic Syndrome and Related Disorders 1, no. 4 (December 2003): 291–98. https://doi.org/10.1089/1540419031361345.
Paccagnini, Daniela, Lee Sieswerda, Valentina Rosu, Speranza Masala, Adolfo Pacifico, Maria Gazouli, John Ikonomopoulos, Niyaz Ahmed, Stefania Zanetti, and Leonardo A. Sechi. “Linking Chronic Infection and Autoimmune Diseases: Mycobacterium Avium Subspecies Paratuberculosis, SLC11A1 Polymorphisms and Type-1 Diabetes Mellitus.” PLOS ONE 4, no. 9 (September 21, 2009): e7109. https://doi.org/10.1371/journal.pone.0007109.
Persaud, Deryck R., and Alma Barranco-Mendoza. “Bovine Serum Albumin and Insulin-Dependent Diabetes Mellitus: Is Cow’s Milk Still a Possible Toxicological Causative Agent of Diabetes?” Food and Chemical Toxicology 42, no. 5 (May 1, 2004): 707–14. https://doi.org/10.1016/j.fct.2004.01.002.
“Plans and Pricing – The Mastering Diabetes Program.” https://www.masteringdiabetes.org/plans/.
Reaven, Gerald M. “Role of Insulin Resistance in Human Disease.” Diabetes 37, no. 12 (December 1, 1988): 1595–1607. https://doi.org/10.2337/diab.37.12.1595.
Reference, Genetics Home. “Type 1 Diabetes.” Genetics Home Reference. https://ghr.nlm.nih.gov/condition/type-1-diabetes.
“Retrospective Evaluation of an Online Diabetes Health Coaching Program: A Pilot Study - Jordan Sarver, Cyrus Khambatta, Robby Barbaro, Bhakti Chavan, David Drozek, 2019.” https://journals.sagepub.com/doi/10.1177/1559827619879106.
“Role of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM | Diabetes.” https://diabetes.diabetesjournals.org/content/46/1/3.
“Role of Insulin Resistance in Human Disease | Diabetes.” https://diabetes.diabetesjournals.org/content/37/12/1595.
Sadeharju, K., A.-M. Hämäläinen, M. Knip, M. Lönnrot, P. Koskela, S. M. Virtanen, J. Ilonen, H. K. Akerblom, H. Hyöty, and Finnish TRIGR Study Group. “Enterovirus Infections as a Risk Factor for Type I Diabetes: Virus Analyses in a Dietary Intervention Trial.” Clinical and Experimental Immunology 132, no. 2 (May 2003): 271–77. https://doi.org/10.1046/j.1365-2249.2003.02147.x.
“The Insulin Resistance Diet Definitive Guide – What to Eat and Why.” https://www.masteringdiabetes.org/reverse-insulin-resistance-presentation/.
“Type 1 Diabetes - Symptoms and Causes - Mayo Clinic.” https://www.mayoclinic.org/diseases-conditions/type-1-diabetes/symptoms-causes/syc-20353011.
Mastering Diabetes. “Type 1 Diabetes Makeover – From Rollercoaster to Full Control,” October 10, 2017. https://www.masteringdiabetes.org/type-1-diabetes-makeover/.
Watson, G. Stennis, and Suzanne Craft. “The Role of Insulin Resistance in the Pathogenesis of Alzheimer’s Disease.” CNS Drugs 17, no. 1 (January 1, 2003): 27–45. https://doi.org/10.2165/00023210-200317010-00003.
“What’s the Difference Between Type 1 and Type 2 Diabetes?” https://www.healthline.com/health/difference-between-type-1-and-type-2-diabetes.
“Why Is Type 1 Diabetes Increasing? In: Journal of Molecular Endocrinology Volume 51 Issue 1 (2013).” https://jme.bioscientifica.com/view/journals/jme/51/1/R1.xml.